Effect of Australia's Walk to Work Day campaign on adults' active commuting and physical activity behavior

PURPOSE: To determine whether Australia's Walk to Work Day media campaign resulted in behavioral change among targeted groups. METHODS: Pre- and postcampaign telephone surveys of a cohort of adults aged 18 to 65 years (n = 1100, 55% response rate) were randomly sampled from Australian major metropolitan areas. Tests for dependent samples were applied (McNemar chi2 or paired t-test). RESULTS: Among participants who did not usually actively commute to work was a significant decrease in "car only" use and an increase in walking combined with public transport. Among those who were employed was a significant increase in total time walking (+ 16 min/wk; t [780] = 2.04, p < .05) and in other moderate physical activity (+120 min/wk; t [1087] = 4.76, p < .005), resulting in a significant decrease in the proportion who were "inactive" (chi2 (1) = 6.1, p <.05). CONCLUSION: Although nonexperimental, the Walk to Work Day initiative elicited shortterm changes in targeted behaviors among target groups. Reinforcement by integrating worksite health promotion strategies may be required for sustained effects.     

Unsaturated phosphatidylcholine and its application in surgical adhesion

BACKGROUND: It has been confirmed that surface-active phospholipid (SAPL), or surfactant, lines the surface of peritoneum and serves as a release and lubricating agent. The most important component in SAPL is phosphatidylcholine. A previous animal study showed that a saturated phosphatidylcholine, dipalmitoyl-phosphatidylcholine, reduced the formation of surgical adhesion. Latest studies have indicated that the dominant SAPL species at some sites outside the lung are not saturated phosphatidylcholine but, rather, are unsaturated phosphatidylcholine. METHODS: High performance liquid chromatography was used to analyse the phosphatidylcholine profile of dialysate samples obtained from peritoneal dialysis patients. Friction tests were performed on dipalmitoyl-phosphatidylcholine and selected unsaturated phosphatidylcholine. RESULTS: It was discovered that unsaturated phosphatidylcholine was the dominant SAPL species inside the peritoneal cavity. They are palmitoyl-linoleoyl-phosphatidylcholine, palmitoyl-oleoylphosphatidylcholine and stearoylarachidonoylphosphatidylcholine. Most interestingly, there was no dipalmitoyl-phosphatidylcholine detected from these dialysate samples. The coefficients of static and dynamic friction from palmitoyllinoleoyl-phosphatidylcholine and palmitoyloleoyl-phosphatidylcholine were measured and found to be lower than that of dipalmitoyl-phosphatidylcholine. CONCLUSION: The results from the current study reveal that unsaturated phosphatidylcholine is the endogenous species inside the peritoneal cavity. This discovery offers further evidence that the dominant SAPL species at non-lung sites are unsaturated phosphatidylcholine, not saturated phosphatidylcholine, strongly indicating the difference between phosphatidylcholine species distribution at lung and non-lung sites. Unsaturated phosphatidylcholine has better anti-friction and lubrication properties than dipalmitoyl-phosphatidylcholine. Unsaturated phosphatidylcholine-based SAPL pharmaceutical products should be developed and evaluated.     

Subgingival microbiota in peri-implant mucosa lesions and adjacent teeth in partially edentulous patients

BACKGROUND: Osseointegrated dental implants have been shown to be a predictable approach to provide the adequate support for the replacement of missing teeth. It has been observed that implants showing signs of peri-implantitis contain subgingival microbiota similar to that around natural teeth with periodontal disease. This study identified the subgingival microbiota around implants with peri-implant lesions and natural teeth in partially edentulous patients. METHODS: Clinical and radiographic parameters were recorded and microbial samples taken from 16 implants with signs of pocketing, 12 neighboring and 11 non-neighboring teeth to the affected implants in 11 patients and 15 stable implants in eight patients (controls). Samples were cultured using techniques for Enterobacteriaceae spp and facultative/anaerobic periodontal pathogens. Statistical analysis included Friedman test to establish differences between the subgingival microbiota cultured from implants and teeth and two-tailed Mann Whitney test and chi square to find differences in two separate samples (P < or = 0.05). RESULTS: There were statistical differences between the subgingival microbiota in peri-implant lesions and stable implants for Gram-negative enteric rods (P <0.05). P. gingivalis (1.42%) was detected in peri-implant lesions but not in stable implants. A significant correlation between the subgingival microbiota from implants and neighboring teeth for Gram-negative enteric rods (P = 0.023) and implants and non-neighboring teeth for P. gingivalis (P = 0.042) was found. The frequency detection of Gram-negative enteric rods (75%) and P. intermedia/nigrescens (25%) was higher in peri-implant lesions (P <0.05). CONCLUSIONS: The subgingival microbiota in peri-implant lesions showed high levels of periodontopathic bacteria and superinfecting bacteria compared to healthy stable implants. The role of superinfecting bacteria in the pathogenesis of peri-implant lesions needs further investigation.     

Intrinsic abnormalities of lymphocyte counts in children with down syndrome

OBJECTIVE: Down syndrome (DS) is associated with an increased frequency of infections, hematologic malignancies, and autoimmune diseases, suggesting that immunodeficiency is an integral part of DS that contributes significantly to the observed increased morbidity and mortality. We determined the absolute counts of the main lymphocyte populations in a large group of DS children to gain further insight into this immunodeficiency. STUDY DESIGN: In a large group of children with DS (n = 96), the absolute numbers of the main lymphocyte subpopulations were determined with 3-color immunophenotyping using the lysed whole-blood method. The results were compared with previously published data in healthy children without DS. RESULTS: In healthy children with DS, the primary expansion of T and B lymphocytes seen in healthy children without DS in the first years of life was severely abrogated. The T- lymphocyte subpopulation counts gradually reached more normal levels with time, whereas the B- lymphocyte population remained severely decreased, with 88% of values falling below the 10th percentile and 61% below the 5th percentile of normal. CONCLUSIONS: The diminished expansion of T and B lymphocytes strongly suggests that a disturbance in the adaptive immune system is intrinsically present in DS and is not a reflection of precocious aging. Thymic alterations have been described in DS that could explain the decreased numbers of T lymphocytes, but not the striking B lymphocytopenia, seen in these children.     

In vivo characterization of the angiotensin-(1-7)-induced dopamine and gamma-aminobutyric acid release in the striatum of the rat

The effect of angiotensin (Ang)-1-7 on dopamine, gamma-aminobutyric acid (GABA) and glutamate release in the striatum of the rat was examined using in vivo microdialysis. Ang-(1-7) was administered locally in the striatum through the microdialysis probe. At a concentration of 100 microm, Ang-(1-7) caused a significant increase in extracellular dopamine and GABA but had no effect on glutamate release. The Ang-(1-7)-induced dopamine release was blocked by EC33, an inhibitor of aminopeptidase A, an enzyme which converts Ang-(1-7) into Ang-(3-7), suggesting that this effect occurs after metabolism into Ang-(3-7). Indeed, administration of Ang-(3-7) (10-100 microm) into the striatum caused a more potent increase in the striatal dopamine release than Ang-(1-7). Because Ang-(3-7) is an inhibitor of insulin-regulated aminopeptidase (IRAP) and because Ang IV, another IRAP inhibitor, also causes a concentration-dependent increase in dopamine in the rat striatum, IRAP may be involved in this effect. In contrast, EC33 had no effect on the Ang-(1-7)-induced GABA increase but the GABA release was blocked by the putative AT(1-7) receptor antagonist A779 (0.1 microm) and by the nitric oxide synthase inhibitor L-NAME (1 mm). These drugs could not block the effect of Ang-(1-7) on the striatal dopamine release suggesting that only the observed effects on GABA release are mediated by the AT(1-7) receptor and/or are associated with a release of nitric oxide.     

A preliminary study of imiquimod treatment in variants of basal cell carcinoma

Imiquimod is a topical immune response modifier that has proved efficacious in the treatment of the superficial variant of basal cell carcinoma. The nodular variant of basal cell carcinoma has shown moderate response to imiquimod; other variants have not been tested. The mechanism of action is largely unknown; however, studies indicate the mechanism involves alteration of local cytokine production. The objective of this study is to evaluate the cytokine response of imiquimod in all variants of basal cell carcinoma. Ten patients were selected who had clinically and histologically proven basal cell carcinoma. All lesions were treated with imiquimod once a day, 5 days a week, for 3 weeks. After a 3-week rest period, the lesions were rebiopsied. All biopsy specimens were analyzed via polymerase chain reaction (PCR) for various cytokines. Nine of 10 lesions resolved clinically, which included nodular, superficial, infiltrative, adenoid, and micronodular variants. The cytokine with the greatest change pre- and post-treatment was IL-8, which decreased an average of 44 per cent (P = 0.06). We concluded that topical 5 per cent imiquimod is an effective treatment of various subtypes of basal cell carcinoma. IL-8, which plays an important role in the development and metastasis of melanoma, may be involved in the mechanism of action of imiquimod on cutaneous malignancies. Larger studies are needed to prove the efficacy of imiquimod on nonsuperficial variants of basal cell carcinoma and cutaneous melanoma metastasis.     

Diabetes outcomes in the Indian health system during the era of the Special Diabetes Program for Indians and the Government Performance and Results Act

OBJECTIVES: We reviewed changes in blood glucose, blood pressure, and cholesterol levels among American Indians and Alaska Natives between 1995 and 2001 to estimate the quality of diabetes care in the Indian Health Service (IHS) health care delivery system. METHODS: We conducted a cross-sectional analysis of data from the Indian Health Service Diabetes Care and Outcomes Audit. RESULTS: Adjusted mean Hemoglobin A1c (HbA1c) levels (7.9% vs 8.9%) and mean diastolic blood pressure levels (76 vs 79 mm Hg) were lower in 2001 than in 1995, respectively. A similar pattern was observed for mean total cholesterol (193 vs 208 mg/dL) and triglyceride (235 vs 257 mg/dL) levels in 2001 and 1995, respectively. CONCLUSIONS: We identified changes in intermediate clinical outcomes over the period from 1995 to 2001 that may reflect the global impact of increased resource allocation and improvements in processes on the quality of diabetes care, and we describe the results that may be achieved when community, health program, and congressional initiatives focus on common goals.